129 related articles for article (PubMed ID: 18837949)
1. Cell-surface-bound circulating DNA as a prognostic factor in lung cancer.
Tamkovich SN; Litviakov NV; Bryzgunova OE; Dobrodeev AY; Rykova EY; Tuzikov SA; Zav'ialov AA; Vlassov VV; Cherdyntseva NV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():214-7. PubMed ID: 18837949
[TBL] [Abstract][Full Text] [Related]
2. RARβ2 gene methylation level in the circulating DNA from blood of patients with lung cancer.
Ponomaryova AA; Rykova EY; Cherdyntseva NV; Skvortsova TE; Dobrodeev AY; Zav'yalov AA; Tuzikov SA; Vlassov VV; Laktionov PP
Eur J Cancer Prev; 2011 Nov; 20(6):453-5. PubMed ID: 21795979
[TBL] [Abstract][Full Text] [Related]
3. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
4. Quantification of plasma DNA as a screening tool for lung cancer.
Xie GS; Hou AR; Li LY; Gao YN; Cheng SJ
Chin Med J (Engl); 2004 Oct; 117(10):1485-8. PubMed ID: 15498370
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.
Carpagnano GE; Spanevello A; Carpagnano F; Palladino GP; Prato R; Martinelli D; Digioia G; Foschino-Barbaro MP
Lung Cancer; 2009 Jun; 64(3):334-40. PubMed ID: 18995925
[TBL] [Abstract][Full Text] [Related]
6. Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients.
Ponomaryova AA; Rykova EY; Cherdyntseva NV; Skvortsova TE; Dobrodeev AY; Zav'yalov AA; Bryzgalov LO; Tuzikov SA; Vlassov VV; Laktionov PP
Lung Cancer; 2013 Sep; 81(3):397-403. PubMed ID: 23806794
[TBL] [Abstract][Full Text] [Related]
7. Deoxyribonuclease activity and circulating DNA concentration in blood plasma of patients with prostate tumors.
Cherepanova AV; Tamkovich SN; Bryzgunova OE; Vlassov VV; Laktionov PP
Ann N Y Acad Sci; 2008 Aug; 1137():218-21. PubMed ID: 18837950
[TBL] [Abstract][Full Text] [Related]
8. Centromere protein H is a novel prognostic marker for human nonsmall cell lung cancer progression and overall patient survival.
Liao WT; Wang X; Xu LH; Kong QL; Yu CP; Li MZ; Shi L; Zeng MS; Song LB
Cancer; 2009 Apr; 115(7):1507-17. PubMed ID: 19170237
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of K-Ras mutations in non-small cell lung cancer: still an issue for open debate.
Neri M; Cesario A; Granone P; Dominioni L; Puntoni R; D'Angelillo RM; Russo P
Lung Cancer; 2006 Sep; 53(3):393-5; author reply 397-8. PubMed ID: 16887233
[TBL] [Abstract][Full Text] [Related]
10. Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.
Hoffmann AC; Kaifi JT; Vallböhmer D; Yekebas E; Grimminger P; Leers JM; Izbicki JR; Hölscher AH; Schneider PM; Metzger R; Brabender J
J Surg Oncol; 2009 Oct; 100(5):414-7. PubMed ID: 19653236
[TBL] [Abstract][Full Text] [Related]
11. Circulating DNA and lung cancer.
Xue X; Zhu YM; Woll PJ
Ann N Y Acad Sci; 2006 Sep; 1075():154-64. PubMed ID: 17108206
[TBL] [Abstract][Full Text] [Related]
12. SCG3 transcript in peripheral blood is a prognostic biomarker for REST-deficient small cell lung cancer.
Moss AC; Jacobson GM; Walker LE; Blake NW; Marshall E; Coulson JM
Clin Cancer Res; 2009 Jan; 15(1):274-83. PubMed ID: 19118055
[TBL] [Abstract][Full Text] [Related]
13. Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer.
Schwarzenbach H; Stoehlmacher J; Pantel K; Goekkurt E
Ann N Y Acad Sci; 2008 Aug; 1137():190-6. PubMed ID: 18837946
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of serum epidermal growth factor receptor level in patients with non-small cell lung cancer.
Ciledağ A; Kaya A; Yetkin O; Poyraz B; Savaş I; Numanoğlu N; Savaş H
Tuberk Toraks; 2008; 56(4):390-5. PubMed ID: 19123074
[TBL] [Abstract][Full Text] [Related]
15. Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression.
Hirata D; Yamabuki T; Miki D; Ito T; Tsuchiya E; Fujita M; Hosokawa M; Chayama K; Nakamura Y; Daigo Y
Clin Cancer Res; 2009 Jan; 15(1):256-66. PubMed ID: 19118053
[TBL] [Abstract][Full Text] [Related]
16. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
Bogos K; Renyi-Vamos F; Dobos J; Kenessey I; Tovari J; Timar J; Strausz J; Ostoros G; Klepetko W; Ankersmit HJ; Lang G; Hoda MA; Nierlich P; Dome B
Clin Cancer Res; 2009 Mar; 15(5):1741-6. PubMed ID: 19240177
[TBL] [Abstract][Full Text] [Related]
17. Potential increase in the prognostic value of p53 mutation by Pro72 allele in stage I non-small-cell lung cancer.
Chien WP; Wong RH; Wu TC; Cheng YW; Chen CY; Lee H
Ann Surg Oncol; 2009 Jul; 16(7):1918-24. PubMed ID: 19434453
[TBL] [Abstract][Full Text] [Related]
18. Is there a subset of patients with preoperatively diagnosed N2 non-small cell lung cancer who might benefit from surgical resection?
Ratto GB; Costa R; Maineri P; Alloisio A; Bruzzi P; Dozin B
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):849-58. PubMed ID: 19660370
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of fluorescence-based methods for total vs. amplifiable DNA quantification in plasma of lung cancer patients.
Szpechcinski A; Struniawska R; Zaleska J; Chabowski M; Orlowski T; Roszkowski K; Chorostowska-Wynimko J
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():675-81. PubMed ID: 19218694
[TBL] [Abstract][Full Text] [Related]
20. [Lung cancer in women: clinical features and factors related to survival].
Sen E; Kaya A; Erol S; Savas I; Gonullu U
Tuberk Toraks; 2008; 56(3):266-74. PubMed ID: 18932027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
